Investor Relations News / Events Press Releases IR Calendar Email Alerts Press Releases All News 2020 2019 2018 2017 2016 2015 2014 Implications of Court Decision in Favor of iBio Against Fraunhofer Aug 15, 2016 iBio, Inc.'s Claims Against Fraunhofer Affirmed by Delaware Chancery Court Aug 4, 2016 iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate Jul 5, 2016 iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis Jun 29, 2016 Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals Jun 7, 2016 iBio, Inc. Holds Annual Meeting in College Station, Texas Apr 7, 2016 iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment Jan 14, 2016 iBio Continues Global Expansion of Intellectual Property Nov 30, 2015 Scientific Insights Into IBIO-CFB03 Presented at American College of Rheumatology Annual Meeting Nov 19, 2015 iBio European Protein Expression Patent Emerges From Opposition Period Oct 27, 2015 1 2 3 4 5 6 7 8
iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis Jun 29, 2016
Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals Jun 7, 2016
iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment Jan 14, 2016
Scientific Insights Into IBIO-CFB03 Presented at American College of Rheumatology Annual Meeting Nov 19, 2015
